Possible Rifampicin-induced Arthritis in a Patient Receiving Anti-tuberculosis Therapy: the First Reported Case
Overview
Overview
Journal
Rheumatology (Oxford)
Publisher
Oxford University Press
Specialty
Rheumatology
Date
2024 May 11
PMID
38733597
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Olivieri I, Salvarani C, Cantini F
. Remitting distal extremity swelling with pitting edema: a distinct syndrome or a clinical feature of different inflammatory rheumatic diseases?. J Rheumatol. 1997; 24(2):249-52.
View
2.
Chiu N, Zhang L, Dent R, Giotis A, Van Draanen J, Gallo-Hershberg D
. A prospective study of docetaxel-associated pain syndrome. Support Care Cancer. 2017; 26(1):203-211.
DOI: 10.1007/s00520-017-3836-z.
View
3.
Girling D
. Adverse reactions to rifampicin in antituberculosis regimens. J Antimicrob Chemother. 1977; 3(2):115-32.
DOI: 10.1093/jac/3.2.115.
View
4.
Shoenfeld Y, Agmon-Levin N
. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2010; 36(1):4-8.
DOI: 10.1016/j.jaut.2010.07.003.
View
5.
Sterling T, Moro R, Borisov A, Phillips E, Shepherd G, Adkinson N
. Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study. Clin Infect Dis. 2015; 61(4):527-35.
PMC: 4560029.
DOI: 10.1093/cid/civ323.
View